The global pandemic caused by the coronavirus has had far-reaching and long-lasting impacts. The disease's entire breadth has yet to be discovered. Initially, there were multiple anecdotal and published reports of eye redness and irritation in COVID-19 patients, implying that conjunctivitis is an ocular symptom of SARS-CoV-2 infection. COVID-19 has been linked to uveitic, retinovascular, and neuro-ophthalmic illness, according to new research. Based on the findings in the patients' eyes, it's been indicated that unprotected eyes can also become infected with the SAR-CoV-2 virus. The drugs used to treat COVID-19 have ocular side effects as well. Although long-term treatment of chloroquine and hydroxychloroquine can cause retinal damage, this is neither expected or seen with COVID-19.
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the aetiological agent of the most dramatic pandemic of the new millennium, the well-known Coronavirus Disease 2019 (COVID-19). It is…
Background: Mucormycosis is a deadly opportunistic fungal infection characterized by direct invasion with marked tissue necrosis of adjacent structures followed by rapid progression and angioinvasion…
Oral and poster slots for original Ophthalmic Manifestations of Coronavirus work, reviewed by the scientific committee.
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Plenary lectures from leading voices shaping Ophthalmic Manifestations of Coronavirus research and practice.
Attend in person in Singapore or join virtually — same program, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Ophthalmic Manifestations of Coronavirus track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Ophthalmic Manifestations of Coronavirus. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Ophthalmic Manifestations of Coronavirus are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IOC 2027 is a hybrid conference — attend the Ophthalmic Manifestations of Coronavirus track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
